Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity

MLA

Guanglin Zhang, et al. “Binding of Human Recombinant Mutant Soluble Ectodomain of FGFR2IIIc to c Subtype of FGFRs: Implications for Anticancer Activity.” Oncotarget, vol. 7, Sept. 2016, pp. 68473–88. EBSCOhost, https://doi.org/10.18632/oncotarget.12067.

APA

Guanglin Zhang, Yan-qing He, Ge Liu, Zhong Liu, Weiyi He, Jun Li, Yi Wang, Jun Xu, Shu-Shu Zhang, Xuesong Yang, Guo-Hua Cheng, & Ju Wang. (2016). Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity. Oncotarget, 7, 68473–68488. https://doi.org/10.18632/oncotarget.12067

Chicago

Guanglin Zhang, Yan-qing He, Ge Liu, Zhong Liu, Weiyi He, Jun Li, Yi Wang, et al. 2016. “Binding of Human Recombinant Mutant Soluble Ectodomain of FGFR2IIIc to c Subtype of FGFRs: Implications for Anticancer Activity.” Oncotarget 7 (September): 68473–88. doi:10.18632/oncotarget.12067.